Skip to main content
Top
Published in: BMC Nephrology 1/2016

Open Access 01-12-2016 | Study protocol

Prospective, multicenter, controlled study of quality of life, psychological adjustment process and medical outcomes of patients receiving a preemptive kidney transplant compared to a similar population of recipients after a dialysis period of less than three years – The PreKit-QoL study protocol

Authors: Véronique Sébille, Jean-Benoit Hardouin, Magali Giral, Angélique Bonnaud-Antignac, Philippe Tessier, Emmanuelle Papuchon, Alexandra Jobert, Elodie Faurel-Paul, Stéphanie Gentile, Elisabeth Cassuto, Emmanuel Morélon, Lionel Rostaing, Denis Glotz, Rebecca Sberro-Soussan, Yohann Foucher, Aurélie Meurette

Published in: BMC Nephrology | Issue 1/2016

Login to get access

Abstract

Background

Treatment of end stage renal disease has an impact on patients’ physical and psychological health, including quality of life (QoL). Nowadays, it is known that reducing the dialysis period has many advantages regarding QoL and medical outcomes. Although preemptive transplantation is the preferred strategy to prevent patients undergoing dialysis, its psychological impact is unknown. Moreover, transplantation can be experienced in a completely different manner among patients who were on dialysis and those who still had a functioning kidney at the time of surgery. Longitudinal data are often collected to allow analyzing the evolution of patients’ QoL over time using questionnaires. Such data are often difficult to interpret due to the patients’ changing standards, values, or conceptualization of what the questionnaire is intended to measure (e.g. QoL). This phenomenon is referred to as response shift and is often linked to the way the patients might adapt or cope with their disease experience. Whether response shift is experienced in a different way among patients who were on dialysis and those who still had a functioning kidney at time of surgery is unknown and will be studied in the PreKit-QoL study (trial registration number: NCT02154815). Understanding the psychological impact of pre-emptive transplantation is an important issue since it can be associated with long-term patient and graft survival.

Methods/Design

Adult patients with a pre-emptive transplantation (n = 130) will be prospectively included along with a control group of patients with a pre-transplant dialysis period < 36 months (n = 260). Only first and single kidney transplantation will be considered. Endpoints include: comparison of change between groups in QoL, anxiety and depressive disorders, perceived stress, taking into account response shift. These criteria will be evaluated every 6 months prior to surgery, at hospital discharge, at three and six months, one and two years after transplantation.

Discussion

The PreKit-QoL study assesses and compares the evolution of QoL and other psychological criteria in preemptive and dialyzed patients taking patients’ adaptation into account through response shift analyses. Our study might help to conceive specific, adapted educational programs and psychological support to prevent a possible premature loss of the kidney as a consequence of non-compliance in patients that may be insufficiently prepared for transplantation.

Trial registration

ClinicalTrials.gov identifier NCT02154815, registered on May 28, 2014
Literature
1.
go back to reference Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005;173:1181–4.PubMedPubMedCentralCrossRef Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005;173:1181–4.PubMedPubMedCentralCrossRef
2.
go back to reference Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725–30.PubMedCrossRef Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725–30.PubMedCrossRef
3.
go back to reference Jaar BG, Chang A, Plantinga L. Can we improve quality of life of patients on dialysis? Clin J Am Soc Nephrol. 2013;8:1–4.PubMedCrossRef Jaar BG, Chang A, Plantinga L. Can we improve quality of life of patients on dialysis? Clin J Am Soc Nephrol. 2013;8:1–4.PubMedCrossRef
4.
go back to reference Loos C, Briançon S, Frimat L, Hanesse B, Kessler M. Effect of end-stage renal disease on the quality of life of older patients. J Am Geriatr Soc. 2003;51:229–33.PubMedCrossRef Loos C, Briançon S, Frimat L, Hanesse B, Kessler M. Effect of end-stage renal disease on the quality of life of older patients. J Am Geriatr Soc. 2003;51:229–33.PubMedCrossRef
5.
go back to reference Griva K, Davenport A, Harrison M, Newman SP. The impact of treatment transitions between dialysis and transplantation on illness cognitions and quality of life - a prospective study. Br J Health Psychol. 2012;17:812–27.PubMedCrossRef Griva K, Davenport A, Harrison M, Newman SP. The impact of treatment transitions between dialysis and transplantation on illness cognitions and quality of life - a prospective study. Br J Health Psychol. 2012;17:812–27.PubMedCrossRef
6.
go back to reference Schipper K, Abma TA, Koops C, Bakker I, Sanderman R, Schroevers MJ. Sweet and sour after renal transplantation: a qualitative study about the positive and negative consequences of renal transplantation. Br J Health Psychol. 2014;19:580–91.PubMedCrossRef Schipper K, Abma TA, Koops C, Bakker I, Sanderman R, Schroevers MJ. Sweet and sour after renal transplantation: a qualitative study about the positive and negative consequences of renal transplantation. Br J Health Psychol. 2014;19:580–91.PubMedCrossRef
7.
go back to reference Huang Y, Samaniego M. Preemptive kidney transplantation: has it come of age? Nephrol Ther. 2012;8:428–32.PubMedCrossRef Huang Y, Samaniego M. Preemptive kidney transplantation: has it come of age? Nephrol Ther. 2012;8:428–32.PubMedCrossRef
8.
go back to reference Griva K, Davenport A, Newman SP. Health-related quality of life and long-term survival and graft failure in kidney transplantation: a 12-year follow-up study. Transplantation. 2013;95:740–9.PubMedCrossRef Griva K, Davenport A, Newman SP. Health-related quality of life and long-term survival and graft failure in kidney transplantation: a 12-year follow-up study. Transplantation. 2013;95:740–9.PubMedCrossRef
9.
go back to reference Khimani N, Chen YH, Mauch PM, Recklitis C, Diller L, Silver B, et al. Influence of new late effects on quality of life over time in Hodgkin lymphoma Survivors: a longitudinal survey study. Ann Oncol. 2013;24:226–30.PubMedCrossRef Khimani N, Chen YH, Mauch PM, Recklitis C, Diller L, Silver B, et al. Influence of new late effects on quality of life over time in Hodgkin lymphoma Survivors: a longitudinal survey study. Ann Oncol. 2013;24:226–30.PubMedCrossRef
10.
go back to reference Kim JH, Kwon SY, Lee JH, Lee YS, Lee CH. Virologic response to therapy increases health-related quality of life for patients with chronic hepatitis B. Clin Gastroenterol Hepatol. 2012;10:291–6.PubMedCrossRef Kim JH, Kwon SY, Lee JH, Lee YS, Lee CH. Virologic response to therapy increases health-related quality of life for patients with chronic hepatitis B. Clin Gastroenterol Hepatol. 2012;10:291–6.PubMedCrossRef
11.
go back to reference Palermo TM, Law E, Churchill SS, Walker A. Longitudinal course and impact of insomnia symptoms in adolescents with and without chronic pain. J Pain. 2012;13:1099–106.PubMedPubMedCentralCrossRef Palermo TM, Law E, Churchill SS, Walker A. Longitudinal course and impact of insomnia symptoms in adolescents with and without chronic pain. J Pain. 2012;13:1099–106.PubMedPubMedCentralCrossRef
12.
go back to reference Ring L, Höfer S, Heuston F, Harris D, O’Boyle CA. Response shift masks the treatment impact on patient reported outcomes (PROs): the example of individual quality of life in edentulous patients. Health Qual Life Outcomes. 2005;3:55.PubMedPubMedCentralCrossRef Ring L, Höfer S, Heuston F, Harris D, O’Boyle CA. Response shift masks the treatment impact on patient reported outcomes (PROs): the example of individual quality of life in edentulous patients. Health Qual Life Outcomes. 2005;3:55.PubMedPubMedCentralCrossRef
13.
go back to reference Bloom JR, Petersen DM, Kang SH. Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors. Psychooncology. 2007;16:691–706.PubMedCrossRef Bloom JR, Petersen DM, Kang SH. Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors. Psychooncology. 2007;16:691–706.PubMedCrossRef
14.
go back to reference Ubel PA, Loewenstein G, Jepson C. Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res. 2003;12:599–607.PubMedCrossRef Ubel PA, Loewenstein G, Jepson C. Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Qual Life Res. 2003;12:599–607.PubMedCrossRef
15.
go back to reference Lelorain S, Tessier P, Florin A, Bonnaud-Antignac A. Posttraumatic growth in long term breast cancer survivors: relation to coping, social support and cognitive processing. J Health Psychol. 2011;17:627–39.PubMedCrossRef Lelorain S, Tessier P, Florin A, Bonnaud-Antignac A. Posttraumatic growth in long term breast cancer survivors: relation to coping, social support and cognitive processing. J Health Psychol. 2011;17:627–39.PubMedCrossRef
16.
go back to reference Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 1999;48:1531–48.PubMedCrossRef Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 1999;48:1531–48.PubMedCrossRef
17.
go back to reference Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med. 1999;48:1507–15.PubMedCrossRef Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med. 1999;48:1507–15.PubMedCrossRef
18.
go back to reference Barclay-Goddard R, Epstein JD, Mayo NE. Response shift: a brief overview and proposed research priorities. Qual Life Res. 2009;18:335–46.PubMedCrossRef Barclay-Goddard R, Epstein JD, Mayo NE. Response shift: a brief overview and proposed research priorities. Qual Life Res. 2009;18:335–46.PubMedCrossRef
19.
go back to reference Luckett T, King MT. Choosing patient-reported outcome measures for cancer clinical research--practical principles and an algorithm to assist non-specialist researchers. Eur J Cancer. 2010;46:3149–57.PubMedCrossRef Luckett T, King MT. Choosing patient-reported outcome measures for cancer clinical research--practical principles and an algorithm to assist non-specialist researchers. Eur J Cancer. 2010;46:3149–57.PubMedCrossRef
20.
go back to reference Schwartz CE, Feinberg RG, Jilinskaia E, Applegate JC. An evaluation of a psychosocial intervention for survivors of childhood cancer: paradoxical effects of response shift over time. Psychooncology. 1999;8:344–54.PubMedCrossRef Schwartz CE, Feinberg RG, Jilinskaia E, Applegate JC. An evaluation of a psychosocial intervention for survivors of childhood cancer: paradoxical effects of response shift over time. Psychooncology. 1999;8:344–54.PubMedCrossRef
21.
go back to reference Schwartz CE, Sprangers MA. Guidelines for improving the stringency of response shift research using the thentest. Qual Life Res. 2010;19:455–64.PubMedCrossRef Schwartz CE, Sprangers MA. Guidelines for improving the stringency of response shift research using the thentest. Qual Life Res. 2010;19:455–64.PubMedCrossRef
22.
go back to reference Schwartz CE, Andresen EM, Nosek MA, Krahn GL, RRTC Expert Panel on Health Status Measurement. Response shift theory: important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil. 2007;88:529–36.PubMedCrossRef Schwartz CE, Andresen EM, Nosek MA, Krahn GL, RRTC Expert Panel on Health Status Measurement. Response shift theory: important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil. 2007;88:529–36.PubMedCrossRef
23.
go back to reference Abecassis M, Bartlett ST, Collins AJ, Davis CL, Delmonico FL, Friedewald JJ, et al. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol. 2008;3:471–80.PubMedPubMedCentralCrossRef Abecassis M, Bartlett ST, Collins AJ, Davis CL, Delmonico FL, Friedewald JJ, et al. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol. 2008;3:471–80.PubMedPubMedCentralCrossRef
24.
go back to reference Beauger D, Gentile S, Jouve E, Dussol B, Jacquelinet C, Briançon S. Analysis, evaluation and adaptation of the ReTransQoL: a specific quality of life questionnaire for renal transplant recipients. Health Qual Life Outcomes. 2013;11:148.PubMedPubMedCentralCrossRef Beauger D, Gentile S, Jouve E, Dussol B, Jacquelinet C, Briançon S. Analysis, evaluation and adaptation of the ReTransQoL: a specific quality of life questionnaire for renal transplant recipients. Health Qual Life Outcomes. 2013;11:148.PubMedPubMedCentralCrossRef
25.
go back to reference Leplège A, Ecosse E, Pouchot J, Coste J, Perneger T. Le questionnaire MOS SF-36 : manuel de l’utilisateur et guide d’interprétation des scores. Paris: Estem; 2001. Leplège A, Ecosse E, Pouchot J, Coste J, Perneger T. Le questionnaire MOS SF-36 : manuel de l’utilisateur et guide d’interprétation des scores. Paris: Estem; 2001.
26.
go back to reference Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction with Life Scale. J Pers Assess. 1985;49:71–5.PubMedCrossRef Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction with Life Scale. J Pers Assess. 1985;49:71–5.PubMedCrossRef
27.
go back to reference Pavot W, Diener E. The Satisfaction with Life Scale and the emerging construct of life satisfaction. J Positive Psychol. 2008;3:137–52.CrossRef Pavot W, Diener E. The Satisfaction with Life Scale and the emerging construct of life satisfaction. J Positive Psychol. 2008;3:137–52.CrossRef
28.
go back to reference Lepine JP, Godchau M, Brun P, Lempérière T, et al. Evaluation of anxiety and depression among patients hospitalized on an internal medicine service. Ann Med Psychol (Paris). 1985;143(2):175–89. Lepine JP, Godchau M, Brun P, Lempérière T, et al. Evaluation of anxiety and depression among patients hospitalized on an internal medicine service. Ann Med Psychol (Paris). 1985;143(2):175–89.
29.
go back to reference Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.PubMedCrossRef Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.PubMedCrossRef
30.
go back to reference Quintard B. Du stress objectif au stress perçu. Introduction à la psychologie de la santé. Paris: PUF; 1994. Quintard B. Du stress objectif au stress perçu. Introduction à la psychologie de la santé. Paris: PUF; 1994.
31.
go back to reference Muller L, Spitz E. Multidimensional assessment of coping: validation of the Brief COPE among French population. Encéphale. 2003;29:507–18.PubMed Muller L, Spitz E. Multidimensional assessment of coping: validation of the Brief COPE among French population. Encéphale. 2003;29:507–18.PubMed
32.
go back to reference Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996;9:455–71.PubMedCrossRef Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996;9:455–71.PubMedCrossRef
33.
go back to reference Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–54.PubMedCrossRef Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–54.PubMedCrossRef
34.
go back to reference Foucher Y, Daguin P, Akl A, Kessler M, Ladrière M, Legendre C, et al. A clinical scoring system highly predictive of long-term kidney graft survival. Kidney Int. 2010;78:1288–94.PubMedCrossRef Foucher Y, Daguin P, Akl A, Kessler M, Ladrière M, Legendre C, et al. A clinical scoring system highly predictive of long-term kidney graft survival. Kidney Int. 2010;78:1288–94.PubMedCrossRef
35.
go back to reference Girerd X, Hanon O, Anangnostopoulos K, Cirepek L, Mourad JJ, Consoli S. Evaluation de l’observance du traitement antihypertenseur par un questionnaire : mise au point et utilisation dans un service spécialisé. Presse Med. 2001;30:1044–8.PubMed Girerd X, Hanon O, Anangnostopoulos K, Cirepek L, Mourad JJ, Consoli S. Evaluation de l’observance du traitement antihypertenseur par un questionnaire : mise au point et utilisation dans un service spécialisé. Presse Med. 2001;30:1044–8.PubMed
36.
go back to reference Bollen K. Structural Equations with Latent Variables. New York: Wiley; 1989.CrossRef Bollen K. Structural Equations with Latent Variables. New York: Wiley; 1989.CrossRef
37.
go back to reference Fisher G, Molenaar I. Rasch Models, Foundations, Recent Developments, and Applications. New York: Wiley; 1995. Fisher G, Molenaar I. Rasch Models, Foundations, Recent Developments, and Applications. New York: Wiley; 1995.
38.
go back to reference Oort FJ. Using structural equation modeling to detect response shifts and true change. Qual Life Res. 2005;14:587–98.PubMedCrossRef Oort FJ. Using structural equation modeling to detect response shifts and true change. Qual Life Res. 2005;14:587–98.PubMedCrossRef
39.
go back to reference Guilleux A, Blanchin M, Vanier A, Guillemin F, Falissard B, Schwartz CE, et al. RespOnse Shift ALgorithm in Item response theory (ROSALI) for response shift detection with missing data in longitudinal patient-reported outcome studies. Qual Life Res. 2015;24:553–64.PubMedCrossRef Guilleux A, Blanchin M, Vanier A, Guillemin F, Falissard B, Schwartz CE, et al. RespOnse Shift ALgorithm in Item response theory (ROSALI) for response shift detection with missing data in longitudinal patient-reported outcome studies. Qual Life Res. 2015;24:553–64.PubMedCrossRef
40.
go back to reference Pinheiro J, Bates D. Mixed-Effects Models in S and S-PLUS. Statistics and Computing. New York: Springer-Verlag; 2000.CrossRef Pinheiro J, Bates D. Mixed-Effects Models in S and S-PLUS. Statistics and Computing. New York: Springer-Verlag; 2000.CrossRef
41.
go back to reference Giral M, Foucher Y, Karam G, Labrune Y, Kessler M, Hurault de Ligny M, et al. Kidney and recipient weight incompatibility reduces long-term graft survival. J Am Soc Nephrol. 2010;21:1022–9.PubMedPubMedCentralCrossRef Giral M, Foucher Y, Karam G, Labrune Y, Kessler M, Hurault de Ligny M, et al. Kidney and recipient weight incompatibility reduces long-term graft survival. J Am Soc Nephrol. 2010;21:1022–9.PubMedPubMedCentralCrossRef
42.
go back to reference Little R, Rubin D. Statistical analysis with missing data. New York: Wiley; 2002.CrossRef Little R, Rubin D. Statistical analysis with missing data. New York: Wiley; 2002.CrossRef
43.
go back to reference Swartz RJ, Schwartz C, Basch E, Cai L, Fairclough DL, McLeod L, et al. The king’s foot of patient-reported outcomes: current practices and new developments for the measurement of change. Qual Life Res. 2011;20:1159–67.PubMedPubMedCentralCrossRef Swartz RJ, Schwartz C, Basch E, Cai L, Fairclough DL, McLeod L, et al. The king’s foot of patient-reported outcomes: current practices and new developments for the measurement of change. Qual Life Res. 2011;20:1159–67.PubMedPubMedCentralCrossRef
44.
go back to reference Hardouin JB, Conroy R, Sebille V. Imputation by the mean score should be avoided when validating a Patient Reported Outcomes questionnaire by a Rasch model in presence of informative missing data. BMC Med Res Methodol. 2011;11:105.PubMedPubMedCentralCrossRef Hardouin JB, Conroy R, Sebille V. Imputation by the mean score should be avoided when validating a Patient Reported Outcomes questionnaire by a Rasch model in presence of informative missing data. BMC Med Res Methodol. 2011;11:105.PubMedPubMedCentralCrossRef
45.
go back to reference Sebille V, Hardouin JB, Mesbah M. Sequential analysis of latent variables using mixed-effect latent variable models: Impact of non-informative and informative missing data. Stat Med. 2007;26:4889–904.PubMedCrossRef Sebille V, Hardouin JB, Mesbah M. Sequential analysis of latent variables using mixed-effect latent variable models: Impact of non-informative and informative missing data. Stat Med. 2007;26:4889–904.PubMedCrossRef
46.
go back to reference De Bock E, Hardouin JB, Blanchin M, Le Neel T, Kubis G, Sébille V. Assessment of score- and Rasch-based methods for group comparison of longitudinal patient-reported outcomes with intermittent missing data (informative and non-informative). Qual Life Res (Quantitative Methods Special Section), 2014, in press. De Bock E, Hardouin JB, Blanchin M, Le Neel T, Kubis G, Sébille V. Assessment of score- and Rasch-based methods for group comparison of longitudinal patient-reported outcomes with intermittent missing data (informative and non-informative). Qual Life Res (Quantitative Methods Special Section), 2014, in press.
47.
go back to reference De Bock E, Hardouin JB, Blanchin M, Le Neel T, Kubis G, Bonnaud-Antignac A, et al: Rasch-family models are more valuable than score-based approaches for analysing patient-reported outcomes with missing data. Stat Methods Med Res 2013 vol. 16, published on line, in press. De Bock E, Hardouin JB, Blanchin M, Le Neel T, Kubis G, Bonnaud-Antignac A, et al: Rasch-family models are more valuable than score-based approaches for analysing patient-reported outcomes with missing data. Stat Methods Med Res 2013 vol. 16, published on line, in press.
48.
go back to reference Thomas ML. The value of item response theory in clinical assessment: a review. Assessment. 2011;18(3):291–307.PubMedCrossRef Thomas ML. The value of item response theory in clinical assessment: a review. Assessment. 2011;18(3):291–307.PubMedCrossRef
Metadata
Title
Prospective, multicenter, controlled study of quality of life, psychological adjustment process and medical outcomes of patients receiving a preemptive kidney transplant compared to a similar population of recipients after a dialysis period of less than three years – The PreKit-QoL study protocol
Authors
Véronique Sébille
Jean-Benoit Hardouin
Magali Giral
Angélique Bonnaud-Antignac
Philippe Tessier
Emmanuelle Papuchon
Alexandra Jobert
Elodie Faurel-Paul
Stéphanie Gentile
Elisabeth Cassuto
Emmanuel Morélon
Lionel Rostaing
Denis Glotz
Rebecca Sberro-Soussan
Yohann Foucher
Aurélie Meurette
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2016
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-016-0225-7

Other articles of this Issue 1/2016

BMC Nephrology 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.